Altimmune (ALT) Depreciation Expense (2016 - 2017)
Historic Depreciation Expense for Altimmune (ALT) over the last 6 years, with Q1 2017 value amounting to $33007.0.
- Altimmune's Depreciation Expense fell 1245.06% to $33007.0 in Q1 2017 from the same period last year, while for Mar 2017 it was $138743.0, marking a year-over-year decrease of 243.04%. This contributed to the annual value of $143437.0 for FY2016, which is 129.45% up from last year.
- Altimmune's Depreciation Expense amounted to $33007.0 in Q1 2017, which was down 1245.06% from $33066.0 recorded in Q4 2016.
- Altimmune's Depreciation Expense's 5-year high stood at $52602.0 during Q1 2013, with a 5-year trough of $32235.0 in Q3 2016.
- Its 5-year average for Depreciation Expense is $38264.3, with a median of $37106.0 in 2015.
- Its Depreciation Expense has fluctuated over the past 5 years, first crashed by 3845.25% in 2013, then skyrocketed by 1021.62% in 2016.
- Over the past 5 years, Altimmune's Depreciation Expense (Quarter) stood at $43438.0 in 2013, then decreased by 15.54% to $36686.0 in 2014, then fell by 10.58% to $32806.0 in 2015, then increased by 0.79% to $33066.0 in 2016, then decreased by 0.18% to $33007.0 in 2017.
- Its Depreciation Expense stands at $33007.0 for Q1 2017, versus $33066.0 for Q4 2016 and $32235.0 for Q3 2016.